Ameritas Investment Partners, Inc. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,995
-16.3%
14,8100.0%0.00%0.0%
Q2 2023$19,105
-2.3%
14,8100.0%0.00%0.0%
Q1 2023$19,549
-27.9%
14,8100.0%0.00%0.0%
Q4 2022$27,102
+59.4%
14,8100.0%0.00%0.0%
Q3 2022$17,000
+6.2%
14,8100.0%0.00%0.0%
Q2 2022$16,000
-63.6%
14,8100.0%0.00%
-50.0%
Q1 2022$44,000
+12.8%
14,8100.0%0.00%
+100.0%
Q4 2021$39,000
-27.8%
14,8100.0%0.00%
-50.0%
Q3 2021$54,000
-15.6%
14,8100.0%0.00%0.0%
Q2 2021$64,000
+25.5%
14,8100.0%0.00%0.0%
Q1 2021$51,000
-1.9%
14,8100.0%0.00%0.0%
Q4 2020$52,000
+44.4%
14,8100.0%0.00%0.0%
Q3 2020$36,000
+56.5%
14,810
+17.4%
0.00%
+100.0%
Q2 2020$23,000
+15.0%
12,6100.0%0.00%0.0%
Q1 2020$20,000
-25.9%
12,6100.0%0.00%0.0%
Q4 2019$27,000
+12.5%
12,6100.0%0.00%0.0%
Q3 2019$24,000
-27.3%
12,6100.0%0.00%
-50.0%
Q2 2019$33,000
+3.1%
12,6100.0%0.00%
+100.0%
Q1 2019$32,000
+10.3%
12,6100.0%0.00%
-50.0%
Q4 2018$29,000
-27.5%
12,6100.0%0.00%0.0%
Q3 2018$40,000
+11.1%
12,6100.0%0.00%0.0%
Q2 2018$36,000
-20.0%
12,6100.0%0.00%0.0%
Q1 2018$45,000
+12.5%
12,610
+21.4%
0.00%0.0%
Q4 2017$40,000
+53.8%
10,3900.0%0.00%
+100.0%
Q3 2017$26,000
-7.1%
10,3900.0%0.00%0.0%
Q2 2017$28,000
+12.0%
10,390
+36.9%
0.00%0.0%
Q1 2017$25,0007,5900.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders